A practical approach to the gut microbiome
In recent years, the gut microbiome has emerged as a pivotal player in human health, with profound implications for various chronic illnesses within and outside…
Tag: Hepatology
Apixaban safer than rivaroxaban in AF with liver disease, doctors say
Doctors can be reassured that apixaban is safe for patients with AF and liver disease, a retrospective cohort study suggests. The Harvard University-led study found…
Spot Dx — Do these brown rings catch your eye?
Sera is a 35-year-old receptionist whose optometrist has recommended she see her GP regarding corneal lesions. Test your clinical know-how by taking the quiz below.…
Hesitate before you aspirate liver cyst infections: world-first expert consensus
Fluoroquinolones and third-generation cephalosporins should be first-line antibiotics for liver cyst infections and ‘preferably’ used for six weeks, new guidance says. An international panel of…
GDM linked to doubled NAFLD risk in offspring: review
Mothers with a history of gestational diabetes have a 50% higher risk of subsequent non-alcoholic fatty liver disease, while the risk is more than doubled…
The bad effects of wonder vitamins and the clinical upside of smoking weed: Cautionary tales of n=1
A little learning is a dangerous thing; Drink deep, or taste not the Pierian spring: × Welcome to AusDoc. Enabling and empowering the medical community…
Experimental drug ‘shows promise’ for treating primary biliary cholangitis
For patients with primary biliary cholangitis, those given seladelpar — a peroxisome proliferator-activated receptor (PPAR) delta agonist — are more likely to have a biochemical…
‘Hawaiian shirts break down barriers’: A GP’s story of treating hep C out of a van
Each Thursday Dr Matt Young and his team hit the road in a Toyota HiAce plastered in VW logos, offering testing and treatment for hepatitis…
‘Screen all T2DM patients for fatty liver disease’: incoming guidelines
GPs could be advised to screen all adults with type 2 diabetes for metabolic dysfunction associated fatty liver disease from next year, a leading hepatologist…
Diabetes in NAFLD drives high rate of decompensated cirrhosis: Aussie study
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows. Age, hypertension and extrahepatic cancer all…
